Semvua Bukheti Kilonzo
Overview
Explore the profile of Semvua Bukheti Kilonzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kilonzo S, Wang Y, Jiang Q, Wu W, Wang P, Ning Q, et al.
Curr Med Sci
. 2019 Oct;
39(5):719-726.
PMID: 31612388
Hepatitis E virus (HEV) infection is a major cause of morbidity in endemic areas. Its consequences among chronic hepatitis B (CHB) patients have been under-reported. The aim of this study...
2.
Zhang X, Zhu L, Zhou Y, Shi A, Wang H, Han M, et al.
BMC Immunol
. 2018 Jun;
19(1):20.
PMID: 29940856
Background: Potassium channel tetramerisation domain containing 9 (KCTD9), a member of KCTD family with a DNA-like pentapeptide repeat domain, was found to be increased particularly in NK cells of patients...
3.
Jiang Q, Han M, Ma K, Chen G, Wan X, Kilonzo S, et al.
World J Gastroenterol
. 2018 Jun;
24(21):2300-2310.
PMID: 29881239
Aim: To evaluate the differences in acute kidney injury (AKI) between acute-on-chronic liver failure (ACLF) and decompensated cirrhosis (DC) patients. Methods: During the period from December 2015 to July 2017,...
4.
Gunda D, Nkandala I, Kilonzo S, Kilangi B, Mpondo B
J Sex Transm Dis
. 2017 Jul;
2017:7075601.
PMID: 28702270
Introduction: HIV still causes high mortality despite use of ART. This study was designed to determine the prevalence and risk factors of mortality among HIV patients receiving ART in northwestern...
5.
Gunda D, Kilonzo S, Mpondo B
Pan Afr Med J
. 2016 May;
23:26.
PMID: 27200131
Introduction: Moderate to severe anemia is an important clinical problem in HIV patients on Highly Active Antiretroviral Therapy. The rate of progression and mortality in this sub group of patients...